Importance of lipids in the nutritional treatment of inflammatory diseases;Importancia de los lípidos en el tratamiento nutricional de las patologías de base inflamatoria

Nutricion Hospitalaria

Volumn 21, Issue SUPPL. 2, 2006, Pages 30-43

  Mesa Garcia M D ^a,b   Aguilera Garcia C M ^a   Gil Hernandez A ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Inst de Nutr Y Tecn de Alimentos   (Spain)

Author keywords

Inflammation; Monounsatured fatty acids; Polyunsatured fatty acids

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; FISH OIL; ICOSANOID; ICOSAPENTAENOIC ACID; LIPID; OLEIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ATHEROSCLEROSIS; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; ENTERIC FEEDING; ENTERITIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; LIPID ABSORPTION; LIPID TRANSPORT; LUNG FIBROSIS; NONHUMAN; PARENTERAL NUTRITION; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 33744939444     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Spector AA: Essentiality of fatty acids. Lipids 1999; 34:1-3.
2. Wijendran V, Hayes KC: Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 2004; 24:597-615.
3. Flickinger BD, Huth PJ: Dietary fats and oils: technologies for improving cardiovascular health. Curr Atheroscler Rep 2004; 6:468-476.
4. Bell SJ, Bradley D, Forse RA, Bristian BR: The new dietary fats in health and disease. J Am Diet Assoc 1997; 97:280-286.
5. Kowdley KV: Lipids and lipid-activated vitamins in chronic cholestatic diseases. Clin Liver Dis 1998; 2:373-389.
6. Morimoto KC, Van Eenennaam AL, Depeters EJ, Medrano JF: Hot Topic: Endogenous Production of n-3 and n-6 Fatty Acids in Mammalian Cells. J Dairy Sci 2005; 88:1142-1146.
7. McCowen KC, Bistrian BR: Essential fatty acids and their derivatives. Curr Opin Gastroenterol 2005; 21:207-215.
8. Qiu X: Biosynthesis of docosahexaenoic acid (DHA, 22:6-4, 7,10,13,16,19): two distinct pathways. Prostaglandins Leukot Essent Fatty Acids 2003; 68:181-186.
9. Nakamura MT, Nara TY: Essential fatty acid synthesis and its regulation in mammals. Prostaglandins Leukot Essent Fatty Acids 2003; 68:145-150.
10. Emken EA, Adolf RO, Duval SM, Nelson GJ: Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects. Lipids 1999; 34:785-791.
11. Smit EN, Muskiet FA, Boersma ER: The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fatty Acids 2004; 71:241-250.
12. Ren Y, Schulz H: Metabolic Functions of the Two Pathways of Oleate β-Oxidation Double Bond Metabolism During the β-Oxidation of Oleic Acid in Rat Heart Mitochondria. J Biol Chem 2003; 278:111-111.
13. Muriana F: Metabolismo de los ácidos grasos. En: Libro blanco de los omega-3. Los ácidos grasos poliinsaturados omega 3 y monoinsaturados tipo oleico y su papel en la salud. Ed. Médica Panamericana, Granada 2004; 35-48.
14. Hiltunen JK, Mursula AM, Rottensteiner H, Wierenga RK, Kastaniotis AJ, Gurvitz A: The biochemistry of peroxisomal beta-oxidation in the yeast Saccharomyces cerevisiae. FEMS Microbiol Rev 2003; 27:35-64.
15. Yu W, Liang X, Ensenauer RE, Vockley J, Sweetman L, Schulz H: Leaky beta-oxidation of a trans-fatty acid: incomplete beta-oxidation of elaidic acid is due to the accumulation of 5-trans-tetradecenoyl-CoA and its hydrolysis and conversion to 5-trans-tetradecenoylcarnitine in the matrix of rat mitochondria. Biol Chem 2004; 10:52160-52167.
16. Pâoletti R, Gotto AM Jr, Hajjar DP: Inflammation in atherosclerosis and implications for therapy. Circulation 2004; 15:20-26.
17. Posnett DN, Yarilin D: Amplification of autoimmune disease by infection. Arthritis Res Ther 2005; 7:74-84.
18. Wong SH, Lord JM: Factors underlying chronic inflammation in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 2004; 52:379-388.
19. Carroll MC: A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 2004; 4:825-831.
20. Danese S, Sans M, Fiocchi C: Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3:394-400.
21. Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Kiss DR, Habr-Gama A: Pharmacological nutrition in inflammatory bowel diseases. Nutr Hosp 2003; 18:57-64.
22. Serhan CN: Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 2005; 8:115-121.
23. Chlopicki S, Lomnicka M, Gryglewski RJ: Obligatory role of lipid mediators in platelet-neutrophil adhesion. Thromb Res 2003; 15:287-292.
24. Yaqoob P: Lipids and the immune response: from molecular mechanisms to clinical applications. Curr Opin Clin Nutr Metab Care 2003; 6:133-150.
25. Zhao Y, Joshi-Barve S, Barve S, Chen LH: Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 2004; 23:71-78.
26. Calder PC: Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61:345-58.
27. Switzer KC, McMurray DN, Morris JS, Chapkin RS: (n-3) Polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes. J Nutr 2003; 133:496-503.
28. Lombardi VRM, Cagiao A, Fernández-Novoa L y cols.: Short term food supplementation effects of a fish derived extract on the immunological status of pregnant rats and their suckings pups. Nut Res 2001; 21:1425-1434.
29. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P: Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 2004; 79:674-681.
30. Wallace FA, Miles EA, Calder PC: Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr 2003; 89:679-689.
31. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79:969-973.
32. Bordin L, Priante G, Musacchio E y cols.: Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells. Biochemistry 2003; 42:4485-4491.
33. Leik CE, Walsh SW. Linoleic acid, but not oleic acid, upregulates production of interleukin-8 by human vascular smooth muscle cells via arachidonic acid metabolites under conditions of oxidative stress. J Soc Gynecol Investig 2005; 12:593-598.
34. Granato D, Blum S, Rossle C, Le Boucher J, Malnoe A, Dutoto G: Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enteral Nutr 2000; 24:113-118.
35. Jakschik BA, Morrison AR, Sprecher H: Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway. J Biol Chem 1983; 10:12797-12800.
36. De La Puerta Vázquez R, Martínez-Domínguez E, Sánchez Perona J, Ruiz-Gutiérrez V: Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. Metabolism 2004; 53:59-65.
37. Gerster H: The use of n-3 PUFAs (fish oil) in enteral nutrition. Int J Vitam Nutr Res 1995; 65:3-20.
38. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA: Fatty acids and lymphocyte functions. Br J Nutr 2002; 87:31-48.
39. Nieto N, Torres MI, Ríos A, Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 2002; 132:11-19.
40. Gil A: Papel de los ácidos grasos monoinsaturados y poliinsaturados en los procesos inflamatorios. En: Libro blanco de los omega-3. Los ácidos grasos poliinsaturados omega-3 y monoinsaturados tipo oleico y su papel en la salud. Ed. Médica Panamericana. 2004; 65-80.
41. Belluzzi A: Polyunsaturated fatty acids (n-3 AGPIs) and inflammatory bowel disease (IBD): pathogenesis and treatment. Eur Rev Med Pharmacol Sci 2004; 8:225-229.
42. Ling SC, Griffiths AM: Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2000; 3:339-344.
43. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334:1557-1560.
44. Lorenz-Meyer H, Bauer P, Nicolay C y cols.: (German Crohn's Disease Study Group). Scand J Gastroenterol 1996; 31:778-785.
45. Goh J, O'Morain CA: Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003; 17:307-320.
46. Geerling BJ, Badart-Smook A, Van Deursen C y cols.: Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 2000; 6:77-84.
47. rd, Graham MF: Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am J Physiol Gastrointest Liver Physiol 2004; 286:528-537.
48. Trebble TM, Arden NK, Wootton SA y cols.: Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 2004; 80:1137-1144.
49. Carty E, Rampton DS, Schneider H, Rutgeerts P, Wright JP: Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's disease. Aliment Pharmacol Ther 2001; 15:1323-1329.
50. Esteve M, Navarro E, Klaassen J y cols.: Plasma and mucosal fatty acid pattern in colectomized ulcerative colitis patients. Dig Dis Sci 1998; 43:1071-1078.
51. Grimminger F, Fuhrer D, Papavassilis C y cols.: Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis. Eur J Clin Invest 1993; 23:706-715.
52. Simopoulos AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21:495-505.
53. Aguilera CM, Ramírez-Tortosa MC, Mesa MD, Gil A: Protective effect of monounsaturated and polyunsaturated fatty acids on the development of cardiovascular disease. Nutr Hops 2001; 16:78-91.
54. 2+-induced oxidation in rabbits with experimental atheroscelrosis. BioFactors 1998; 8:79-85.
55. Aguilera CM, Ramírez Tortosa MC, Mesa MD, Ramírez-Tortosa CL, Gil A: Sunflower, virgin olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 2002; 162:335-344.
56. Sato M, Shibata K, Nomura R, Kawamoto D, Nagamine R, Imaizumi K: Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats. Br J Nutr 2005; 94:896-901.
57. Ramírez-Tortosa MC, López-Pedrosa JM, Suárez A, Ros E, Mataix J, Gil A: Olive oil and fish oil enriched diets modify plasma lipids and susceptiblility of low density lipoprotein to oxidative modification in free-living male patients with peripheral vascular disease: the Spanish Nutrition Study. Br J Nutr 1999, 82:31-39.
58. Ramírez-Tortosa MC, Suarez A, González MC, Mir A, Ros E, Mataix J, Gil A: Effect of extra virgin olive oil and fish-oil supplementation on plasma lipids and susceptibility of low-density lipoprotein to oxidative alteration in free-living Spanish male patients with peripheral vascular disease. Clin Nutr 1999, 18:167-174.
59. Shi Q, Vandeberg JF, Jett C y cols.: Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet. Am J Clin Nutr 2005; 82:751-759.
60. De Caterina R, Libby P: Control of endothelial-leukocyte adhesion molecules by n-3 fatty acids. Lipids 1996; 31:557-563.
61. Carrero JJ, Martín-Bautista E, Baro L y cols.: Cardiovascular effects of omega-3-fatty acids and alternatives to increase their intake. Nutr Hops 2005; 20:63-69.
62. Nieto N, Fernández MI, Torres MI, Ríos A, Suárez MD, Gil A: Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant ulcerative colitis induced by trinitobenzen sulfonic acid. Digest Dis Sci 1998; 43:2676-2687.
63. Yaqoob P: Lipids and immune response. Curr Opin Clin Nutr Metab Care 1998; 1:153-161.
64. Khan BV, Parthasarathy S, Alexander RW, Medford RM: Modified LDL and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995; 95:1262-1270.
65. Hubbard NE, Chapkin RS, Erickson KE: Effect of dietary linseed oil on tumoricidal activity and eicosanoid production in murine macrophages. Lipids 1994; 29:651-655.
66. Khair-EL-Din T, Sicher SC, Vázquez MA, Chung GW, Stalworth KA, Kitamura K: Transcription of the murine INOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as weil as fish oils. J Exp Med 1996; 183:1241-1246.
67. Lusis AJ: Atherosclerosis. Nature 2000; 407:233-241.
68. Aguilera CM, Mesa MD, Ramírez-Tortosa MC, Nestares MT, Ros E, Gil A: Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr 2004; 23:673-681.
69. González-Santiago M, Martín-Bautista E, Carrero JJ y cols.: One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 2005; 17.]
70. Kamada C, Da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J: Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res 2005; 39:185-94.
71. Robinson DR, Urakazr M, Huang R, Taki H, Sugiyama E, Knoell CT: Dietary marine lipids supress continous expression of interleukin-1β gene transcription. Lipids 1996; 31:23-31.
72. Fernández G, Chandresekar B, Luan X, Troyer DA. Modulation of antioxidant encimes and programmed cell death by n-3 fatty acids. Lipids 1996; 31:91-96.
73. Larqué E, Zamora S, Gil A: Dietary trans fatty acids in early life: a review. Early Hum Dev 2001; 65: 31-41.
74. Lasztity N, Hamvas J, Biro L y cols.: Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis - a prospective randomized clinical trial. Clin Nutr. 2005; 24:198-205.
75. Calder PC: N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003; 8:343-352.
76. Pattison DJ, Symmons DP, Young A: Does diet have a role in the aetiology of rheumatoid arthritis? Proc Nutr Soc 2004; 63:137-143.
77. Oh R: Practical applications of fish oil (Omega-3 fatty acids) in primary care. J Am Board Fam Pract 2005; 18:28-36.
78. Kremer JM: N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 2000; 71:349-351.
79. Kremer JM, Lawrence DA, Jubiz W y cols.: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990; 33:810-820.
80. Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I: Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 2005; 21:131-136.
81. Fan YY, Chapkin RS: Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 1998; 128:1411-1414.
82. Schwartz J: Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr 2000; 7:393-396.
83. Gil A: Papel de los ácidos grasos poliinsaturados en la piel, enfermedades de la piel y otras patologías emergentes. En: Libro blanco de los omega-3. Los ácidos grasos poliinsaturados omega-3 y monoinsaturados tipo oleico y su papel en la salud. Ed. Médica Panamericana, 2004; 99-110.
84. Schwartz J, Weiss ST: The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Eur Respir J 1994; 7:1821-1824.
85. Schwartz J, Weiss ST: Dietary factors and their relation to respiratory symptoms. The Second National Health and Nutrition Examination Survey. Am J Epidemiol 1990; 132:67-76.
86. Shahar E, Folsom AR, Melnick SL, Tockman MS y cols.: Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 1994; 28:228-233.
87. Jaber R: Respiratory and allergic diseases: from upper respiratory tract infections to asthma. Prim Care 2002; 29:231-261.
88. Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K: Dietary supplementation with fish oil rich in n-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000; 16: 861-865.
89. Wong KW: Clinical efficacy of n-3 fatty acid supplementation in patients with asthma. Am Diet Assoc 2005; 105:98-105.
90. Ziboh VA, Naguwa S, Vang K y cols.: Suppression of leukotriene B4 generation by ex vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin Dev Immunol 2004 11:13-21.
91. Farkas E, Luiten PG: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64:575-611.
92. Horrocks LA, Farooqui AA: Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 2004; 70:361-372.
93. Morris MC, Evans DA, Bienias JL y cols.: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60:940-946.
94. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D: Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 1:33-41.
95. Kalmijn S, Van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ: Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004; 27:2752-2780.
96. Wakai K, Kawamura T, Matsuo S, Hotta N, Ohno Y: Risk factors for IgA nephropathy: a case-control study in Japan. Am J Kidney Dis 1999; 33:738-745.
97. Holman RT, Johnson SB, Bibus D, Spencer DC, Donadio JV Jr: Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy. Am J Kidney Dis 1994; 23:648-654.
98. De Caterina R, Endres S, Kristensen SD, Schmidt EB: n-3 fatty acids and renal diseases. Am J Kidney Dis 1994; 24:397-415.
99. Donadio JV: Use of fish oil to treat patients with immunoglobulin A nephropathy. Am J Clin Nutr 2000; 71:373-375.
100. Donadio JV, Grande JP: The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy. Semin Nephrol 2004; 24:225-224
101. Donadio JV: n-3 Fatty acids and their role in nephrologic practice. Curr Opin Nephrol Hypertens 2001; 10:639-642.
102. Jia Q, Zhou HR, Bennink M, Pestka JJ: Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J Nutr 2004; 134:3343-3349.
103. Sulikowska B, Nieweglowski T, Manitius J, Lysiak-Szydlowska W, Rutkowski B: Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy. Am J Nephrol 2004; 24:474-482.
104. Alexopoulos E, Stangou M, Pantzaki A, Kirmizis D, Memmos D: Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a "very low dose" regimen. Ren Fail 2004; 26:453-459.
105. Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S: Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy. J Med Assoc Thai 2004; 87:143-149.
106. Culebras-Fernández JM, De Paz-Arias R, Jorquera-Plaza F, García de Lorenzo A: Nutrition in the surgical patient: immunonutrition. Nutr Hops 2001; 16:67-77.
107. Chuntrasakul C, Siltham S, Sarasombath S y cols.: Comparison of a immunonutrition formula enriched arginine, glutamine and omega-3 fatty acid, with a currently high-enriched enteral nutrition for trauma patients. Med Assoc Thai 2003; 86:552-561.
108. Horrobin DF: Essential fatty acid metabolism and its modification in atopic eczema. Am J Clin Nutr 2000; 71:367-372.
109. Martínez M: Restoring the DHA levels in the brains of Zellweger patients. J Mol Neurosci 2001; 16:309-321.